Indazole derivatives
US8071628B2 · kind B2 · utility
1Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 2010 |
| Grant date | Dec 6, 2011 |
| Priority date | — |
| Expiry date | Sep 8, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is concerned with novel indazole derivatives of formula (I)wherein R1, R2, R3, R4, R5, R6, X and Y are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit L-CPT1 and can be used in the prevention or treatment of diseases which are modulated by L-CPT1 inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.